| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Financial Officer
3 companies
Daniel K Spiegelman is EVP, Chief Financial Officer at BMRN, with reported holdings spanning 3 companies. From May 2016 to May 2025, the filings on record show 0 open-market purchases and 17 sales. Daniel K Spiegelman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.9M at current prices.
Our model assigns Daniel K Spiegelman a middling insider score of 59/100, based on 6 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +33.7%.
Daniel K Spiegelman's largest disclosed position is in BMRN as EVP, Chief Financial Officer, worth about $2.7M. The BMRN filings lean toward selling, a net 125,414 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sell | 2,303 | $93.32 | $214,915.96 | -10.0% | |
| Mar 1, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 35,000 | $94.07 | $3,292,500.00 | -58.0% | |
| Jan 9, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sell | 5,000 | $90.00 | $450,000.00 | -21.6% | |
| Nov 9, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sell | 20,000 | $90.61 | $1,812,206.00 | -46.4% | |
| Aug 1, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sell | 4,000 | $99.33 | $397,320.00 | -8.5% | |
| Jun 6, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sell | 1,649 | $89.14 | $146,991.86 | -3.4% | |
| May 31, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 20,841 | $89.88 | $1,873,125.75 | -29.3% |